34424117 35677756 33465773 33789118 33358985 36313019 34808322 36605549 35295337 33278560 34331705 32758518 32545780 33686256 32813239 35056793 36270830 36567416 33953960 34119623 35715418 35382723 35056822 36551756 - Search Results

Year	Number of Results
2020	6
2021	10
2022	12
2023	0

1

The CB2 cannabinoid receptor as a therapeutic target in the central nervous system.

Cabañero D, Martín-García E, Maldonado R. Cabañero D, et al. Expert Opin Ther Targets. 2021 Aug;25(8):659-676. doi: 10.1080/14728222.2021.1971196. Epub 2021 Sep 23. Expert Opin Ther Targets. 2021. PMID: 34424117 Review.

2

Cannabinoid 1/2 Receptor Activation Induces Strain-Dependent Behavioral and Neurochemical Changes in Genetic Absence Epilepsy Rats From Strasbourg and Non-epileptic Control Rats.

De Deurwaerdère P, Casarrubea M, Cassar D, Radic M, Puginier E, Chagraoui A, Crescimanno G, Crunelli V, Di Giovanni G. De Deurwaerdère P, et al. Front Cell Neurosci. 2022 May 23;16:886033. doi: 10.3389/fncel.2022.886033. eCollection 2022. Front Cell Neurosci. 2022. PMID: 35677756 Free PMC article.

3

Alpha-Synuclein: The Interplay of Pathology, Neuroinflammation, and Environmental Factors in Parkinson's Disease.

He S, Zhong S, Liu G, Yang J. He S, et al. Neurodegener Dis. 2020;20(2-3):55-64. doi: 10.1159/000511083. Epub 2021 Jan 19. Neurodegener Dis. 2020. PMID: 33465773 Free article. Review.

4

Cannabinoid CB₂ receptors are expressed in glutamate neurons in the red nucleus and functionally modulate motor behavior in mice.

Zhang HY, Shen H, Gao M, Ma Z, Hempel BJ, Bi GH, Gardner EL, Wu J, Xi ZX. Zhang HY, et al. Neuropharmacology. 2021 May 15;189:108538. doi: 10.1016/j.neuropharm.2021.108538. Epub 2021 Mar 28. Neuropharmacology. 2021. PMID: 33789118 Free PMC article.

5

Healing autism spectrum disorder with cannabinoids: a neuroinflammatory story.

Carbone E, Manduca A, Cacchione C, Vicari S, Trezza V. Carbone E, et al. Neurosci Biobehav Rev. 2021 Feb;121:128-143. doi: 10.1016/j.neubiorev.2020.12.009. Epub 2020 Dec 21. Neurosci Biobehav Rev. 2021. PMID: 33358985 Review.

6

Targeting the inflammasome in Parkinson's disease.

Su Q, Ng WL, Goh SY, Gulam MY, Wang LF, Tan EK, Ahn M, Chao YX. Su Q, et al. Front Aging Neurosci. 2022 Oct 12;14:957705. doi: 10.3389/fnagi.2022.957705. eCollection 2022. Front Aging Neurosci. 2022. PMID: 36313019 Free PMC article.

7

Parkinson's disease related alterations in cannabinoid transmission.

Soti M, Ranjbar H, Kohlmeier KA, Shabani M. Soti M, et al. Brain Res Bull. 2022 Jan;178:82-96. doi: 10.1016/j.brainresbull.2021.11.009. Epub 2021 Nov 20. Brain Res Bull. 2022. PMID: 34808322 Review.

8

Editorial: Cannabinoids in neuroinflammation, neurodegeneration and pain: Focus on non-neuronal cells.

Vecchiarelli HA, Joers V, Tansey MG, Starowicz K. Vecchiarelli HA, et al. Front Neurosci. 2022 Dec 20;16:1114775. doi: 10.3389/fnins.2022.1114775. eCollection 2022. Front Neurosci. 2022. PMID: 36605549 Free PMC article. No abstract available.

9

Candidate Therapeutics by Screening for Multitargeting Ligands: Combining the CB2 Receptor With CB1, PPARγ and 5-HT4 Receptors.

El-Atawneh S, Goldblum A. El-Atawneh S, et al. Front Pharmacol. 2022 Feb 28;13:812745. doi: 10.3389/fphar.2022.812745. eCollection 2022. Front Pharmacol. 2022. PMID: 35295337 Free PMC article.

10

Glutaminase in microglia: A novel regulator of neuroinflammation.

Ding L, Xu X, Li C, Wang Y, Xia X, Zheng JC. Ding L, et al. Brain Behav Immun. 2021 Feb;92:139-156. doi: 10.1016/j.bbi.2020.11.038. Epub 2020 Dec 3. Brain Behav Immun. 2021. PMID: 33278560 Free article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results